Cholesteryl ester-loaded macrophages (foam cells), a prominent and early feature of atherosclerotic lesions, form by the interaction of atherogenic lipoproteins with macrophages and the stimulation of intracellular cholesterol esterification by acyl-CoA:cholesterol acyl transferase (ACAT). Two atherogenic lipoprotein pathways which stimulate macrophage ACAT and induce foam cells are Beta-VLDL, internalized via the LDL receptor, and modified forms of LDL (e.g. acetyl-LDL and oxidized LDL), internalized via the scavenger receptor. The long-term objective of this proposal is to explore the cellular and molecular mechanisms responsible for ACAT stimulation and foam cell formation by these two atherogenic pathways. In particular, the Beta-VLDL pathway is characterized by endocytic targeting to a distinct set of widely- distributed vesicles that may be related to its relative potency as an ACAT stimulator.
Specific Aim #1 of the proposal will use a combination of fluorescence microscopy and biochemical techniques to explore several key properties of the Beta-VLDL-containing vesicles, including intravesicular Ph, presence of the LDL receptor, evidence of intravesicular particle disruption, cellular fate of the vesicles, and the presence of relevant enzymatic activities (especially cholesteryl ester hydrolase) and protein markers. The results of these studies will elucidate when and how endocytosed Beta-VLDL lipid (especially Beta- VLDL-cholesteryl ester) and protein are degraded and thus will be important for understanding how the special Beta-VLDL endocytic pathway is related to ACAT stimulation and other aspects of Beta-VLDL metabolism by macrophages.
Specific Aim #2 will focus on the properties of Beta- VLDL particles that lead to their targeting to the peripheral vesicles and their potency as ACAT stimulators. In particular, the role of multi- valent apoprotein E on the surface of large Beta-VLDL particles in endocytic targeting and ACAT stimulation will be addressed. The approach will be to determine the effect of apo E depletion, repletion, and modification of Beta-VLDL particles and lipid emulsions on patterns of endocytosis and ACAT stimulation. Lastly, the proposal will also focus on the other major pathway of foam cell formation--the scavenger receptor. Preliminary work has disclosed that a factor likely to be present in atherosclerotic lesions, transforming growth factor Beta1 (TGF-Beta1), inhibits the induction of scavenger receptors as THP-1 human monocytes differentiate into macrophages.
In Specific Aim #3, the mechanisms (e.g. transcriptional vs. post-transcriptional), extent (relationship to other means of scavenger receptor regulation), and possible physiological consequences (e.g. applicability to an in vivo model of foam cell formation) of this effect will be explored. In summary, we will explore several specific hypotheses and findings regarding two major pathways of macrophage ACAT stimulation and foam cell formation. Knowledge gained from these studies will provide important information regarding macrophage intracellular lipoprotein metabolism in particular and atherogenesis in general.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL039703-08
Application #
2219326
Study Section
Physiological Chemistry Study Section (PC)
Project Start
1988-03-01
Project End
1997-02-28
Budget Start
1995-03-01
Budget End
1996-02-29
Support Year
8
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Tabas, I (1999) Secretory sphingomyelinase. Chem Phys Lipids 102:123-30
Marathe, S; Schissel, S L; Yellin, M J et al. (1998) Human vascular endothelial cells are a rich and regulatable source of secretory sphingomyelinase. Implications for early atherogenesis and ceramide-mediated cell signaling. J Biol Chem 273:4081-8
Schissel, S L; Keesler, G A; Schuchman, E H et al. (1998) The cellular trafficking and zinc dependence of secretory and lysosomal sphingomyelinase, two products of the acid sphingomyelinase gene. J Biol Chem 273:18250-9
Zha, X; Pierini, L M; Leopold, P L et al. (1998) Sphingomyelinase treatment induces ATP-independent endocytosis. J Cell Biol 140:39-47
Tabas, I (1997) Phospholipid metabolism in cholesterol-loaded macrophages. Curr Opin Lipidol 8:263-7
Zha, X; Tabas, I; Leopold, P L et al. (1997) Evidence for prolonged cell-surface contact of acetyl-LDL before entry into macrophages. Arterioscler Thromb Vasc Biol 17:1421-31
Skiba, P J; Zha, X; Maxfield, F R et al. (1996) The distal pathway of lipoprotein-induced cholesterol esterification, but not sphingomyelinase-induced cholesterol esterification, is energy-dependent. J Biol Chem 271:13392-400
Schissel, S L; Schuchman, E H; Williams, K J et al. (1996) Zn2+-stimulated sphingomyelinase is secreted by many cell types and is a product of the acid sphingomyelinase gene. J Biol Chem 271:18431-6
Schissel, S L; Tweedie-Hardman, J; Rapp, J H et al. (1996) Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins. J Clin Invest 98:1455-64
Tabas, I; Marathe, S; Keesler, G A et al. (1996) Evidence that the initial up-regulation of phosphatidylcholine biosynthesis in free cholesterol-loaded macrophages is an adaptive response that prevents cholesterol-induced cellular necrosis. Proposed role of an eventual failure of this response in foam c J Biol Chem 271:22773-81

Showing the most recent 10 out of 30 publications